Inmunotek S.L.

Works in ENT · Immunology · Infectious disease · Renal & urogenital · Respiratory · Women's health

Inmunotek S.L. is a clinical trial sponsor. It has 11 active clinical trials with 2,096 planned participants, across 6 therapeutic areas. Since 2021 it has completed 8 trials and stopped 1 early.

Trial track record · since 2021

11Active trials2,096 planned participants
8Completed3 with results posted
1Stopped early11% of finished trials

Pipeline · 11 active trials

StageTrialStatus

Questions about Inmunotek S.L

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Inmunotek S.L..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.